BLTE Stock Analysis: Buy, Sell, or Hold?
BLTE - Belite Bio, Inc American Depositary Shares
$150.95
5.86 (4.04%)
▲
5d:
+9.23%
30d:
+9.94%
90d:
+0.08%
BUY
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Get Alerted When BLTE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: BLTE shows positive signals but monitor for confirmation. Market pricing in 6.1% decline. Moderate conviction.
💡 BUY OPPORTUNITY: BLTE shows positive signals but monitor for confirmation. Market pricing in 6.1% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$33.08
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$20.54
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BLTE is currently trading at $150.95, which is considered extended relative to its 30-day fair value range of $138.30 to $146.58. From a valuation perspective, the stock is trading at a discount (Forward PE: 153.7) compared to its historical average (185.8). Remarkably, the market is currently pricing in an annual earnings decline of 6.1% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, BLTE is in a strong downtrend. The price is approaching resistance at $151.99. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.0% recently.
Market Sentiment: BLTE has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $210.50 (+45.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BLTE is in a strong downtrend. The price is approaching resistance at $151.99. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.0% recently.
Market Sentiment: BLTE has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $210.50 (+45.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$138.30 -
$146.58
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.0%)
- BULLISH: Trading 45.1% below Wall St target ($210.50)
Trading Range Analysis
30-Day Trading Range
$138.30 -
$146.58
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$135.00
Resistance Level
$151.99
Current Trend
Strong Downtrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
153.65
Wall Street Target
$210.50
(+45.1%)
Valuation Discount vs History
-6.1% cheaper
PE vs Historical
153.7 vs 185.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.1%
(market-implied from PE analysis)
1-Year Target
$136.24
(-6%)
2-Year Target
$127.93
(-12%)
3-Year Target
$120.13
(-17%)
3-Yr Target (if PE normalizes)
(PE: 154→186)
$145.26
(+0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 153.6 to 185.8
Stabilization Target:
$175.45
(+20.9%)
PE Expansion Potential:
+20.9%
Share & Embed Analysis
Last updated: June 24, 2026 10:52 AM ET
Data refreshes hourly during market hours. Next update: 11:52 AM
Data refreshes hourly during market hours. Next update: 11:52 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BLTE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Nathan L Mata
SELL
1000 shares
2026-04-22
Nathan L Mata
SELL
1000 shares
2026-04-20
Nathan L Mata
SELL
1000 shares
2026-04-17
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 64 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 59 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 62 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 65 BUY |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$51 | 63 BUY |
